Sustained Engraftment and Tissue Enzyme Activity After Liver Cell Transplantation for Argininosuccinate Lyase Deficiency
Background & Aims: Donor cell engraftment with expression of enzyme activity is the goal of liver cell transplantation for inborn errors of liver metabolism with a view to achieving sustained metabolic control. Methods: Sequential hepatic cell transplantations using male and female cells were performed in a 3.5-year-old girl with argininosuccinate lyase deficiency over a period of 5 months. Beside clinical, psychomotor, and metabolic follow-up, engraftment was analyzed in repeated liver biopsies (2.5, 5, 8, and 12 months after first infusion) by fluorescence in situ hybridization for the Y-chromosome and by measurement of tissue enzyme activity. Results: Metabolic control was achieved together with psychomotor catch-up, changing the clinical phenotype from a severe neonatal one to a moderate late-onset type. The child was no longer hospitalized and was able to attend normal school. Sustained engraftment of male donor liver cells was shown in repeated biopsies, reaching 19% at 8 months and 12.5% at the 12-month follow-up. XXYY tetraploid donor cells were mainly detected during the infusion period (2.5- and 5-month biopsies), whereas in the follow-up 8-month and 1-year biopsies, diploid donor cell subpopulations had become dominant. Moreover, argininosuccinate lyase activity, originally absent, became measurable in 2 different biopsy samples at 8 months, reaching 3% of control activity, indicating in situ metabolic effect and supporting the clinical evolution to a moderate form of the disease. Conclusions: Liver cell transplantation can achieve donor cell engraftment in humans in a significant proportion, leading to sustained metabolic and clinical control with psychomotor catch-up.
Abbreviations used in this paper: ASA, argininosuccinic acid , ASL, argininosuccinate lyase , CK-7, cytokeratin-7 , FISH, fluorescence in situ hybridization , LCT, liver cell transplantation , OLT, orthotopic liver transplantation
The Liver Cell Transplantation Program is supported by the DGTRE, région wallonne (Grant WALEO/HEPATERA). The Cell Cryopreservation Program is supported by a Grant-Télévie-Fonds National de la Recherche Scientifique.
PII: S0016-5085(06)00009-6
doi:10.1053/j.gastro.2006.01.008
© 2006 American Gastroenterological Association Institute. Published by Elsevier Inc. All rights reserved.


